Licensed alternatives for weight management, including semaglutide (Wegovy) and liraglutide (Saxenda), are available through regulated NHS and private pathways following NICE appraisal
Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
Premium BPC-157 capsules for recovery, inflammation support, and performance
BPC-157 operates mainly through growth hormone receptor upregulation in connective tissue, NO-dependent angiogenic and cytoprotective signalling, FAK-paxillin pathway activation, and neurotransmitter system modulation , producing particularly pronounced effects on gastrointestinal cytoprotection, tendon-to-bone healing, and CNS neuroprotection alongside its broader tissue repair biology
Scalp skin has different absorption characteristics, and the hair follicle cycle operates independently of the circadian rhythm
